CORRIGENDUM: Implementing Pharmacogenomics in Europe: Design and Implementation Strategy of the Ubiquitous Pharmacogenomics Consortium.

Autor: van der Wouden, CH, Cambon‐Thomsen, A, Cecchin, E, Cheung, KC, Dávila‐Fajardo, CL, Deneer, VH, Dolžan, V, Ingelman‐Sundberg, M, Jönsson, S, Karlsson, MO, Kriek, M, Mitropoulou, C, Patrinos, GP, Pirmohamed, M, Samwald, M, Schaeffeler, E, Schwab, M, Steinberger, D, Stingl, J, Sunder‐Plassmann, G

Publikováno v: Clinical Pharmacology & Therapeutics; Jul2017, Vol. 102 Issue 1, p152-152, 1p

Genetic polymorphisms in ADRB1, ADRB2 and CYP2D6 genes and response to beta-blockers in patients with acute coronary syndrome.

Autor: Castaño-Amores C; Pharmacy Department, Hospital Universitario Santa Bárbara, Puertollano, Spain., Antúnez-Rodríguez A; GENYO, Genomics Unit, Centre for Genomics and Oncological Research: Pfizer, University of Granada, Andalusian Regional Government (GENYO), Granada, Spain., Pozo-Agundo A; GENYO, Genomics Unit, Centre for Genomics and Oncological Research: Pfizer, University of Granada, Andalusian Regional Government (GENYO), Granada, Spain., García-Rodríguez S; GENYO, Genomics Unit, Centre for Genomics and Oncological Research: Pfizer, University of Granada, Andalusian Regional Government (GENYO), Granada, Spain., Martínez-González LJ; University of Granada, Department of Biochemistry and Molecular Biology III and Immunology, Faculty of Medicine, PTS, Granada, Spain., Dávila-Fajardo CL; Pharmacy Department, Instituto de Investigación Biosanitaria de Granada (ibs.Granada), Hospital Universitario Virgen de las Nieves, Granada, Spain. Electronic address: cristinal.davila.sspa@juntadeandalucia.es.

Publikováno v: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2023 Dec 31; Vol. 169, pp. 115869. Date of Electronic Publication: 2023 Nov 10.

A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study.

Autor: Swen JJ; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Centre, Leiden, Netherlands., van der Wouden CH; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Centre, Leiden, Netherlands., Manson LE; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Centre, Leiden, Netherlands., Abdullah-Koolmees H; Division Laboratories, Pharmacy and Biomedical Genetics, Hospital Pharmacy, University Medical Centre Utrecht, Utrecht, Netherlands., Blagec K; Centre for Medical Statistics, Informatics and Intelligent Systems, Institute of Artificial Intelligence, Medical University of Vienna, Vienna, Austria., Blagus T; Pharmacogenetics Laboratory, Institute of Biochemistry and Molecular Genetics, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia., Böhringer S; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Centre, Leiden, Netherlands; Department of Biomedical Data Sciences, Leiden University Medical Centre, Leiden, Netherlands., Cambon-Thomsen A; CNRS, Centre for Epidemiology and Research in Population health (CERPOP), Université de Toulouse, Inserm, UPS, Toulouse, France., Cecchin E; Experimental and Clinical Pharmacology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy., Cheung KC; Medicines Information Centre, Royal Dutch Pharmacists Association (KNMP), The Hague, Netherlands., Deneer VH; Division Laboratories, Pharmacy and Biomedical Genetics, Hospital Pharmacy, University Medical Centre Utrecht, Utrecht, Netherlands; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Netherlands., Dupui M; Service de pharmacologie médicale et clinique, CEIP-addictovigilance de Toulouse, faculté de médecine, CHU, Toulouse, France., Ingelman-Sundberg M; Department of Physiology and Pharmacology, Karolinska Institutet, Biomedicum, Stockholm, Sweden., Jonsson S; Department of Pharmacy, Uppsala University, Uppsala, Sweden., Joefield-Roka C; Department of Medicine III, Division of Nephrology and Dialysis, Medical University of Vienna, Vienna, Austria., Just KS; Institute of Clinical Pharmacology, University Hospital RWTH Aachen, Aachen, Germany., Karlsson MO; Department of Pharmacy, Uppsala University, Uppsala, Sweden., Konta L; Bio.logis Digital Health, Frankfurt am Main, Germany., Koopmann R; Bio.logis Digital Health, Frankfurt am Main, Germany; Diagnosticum Centre for Humangenetics, Frankfurt am Main, Germany., Kriek M; Department of Clinical Genetics, Leiden University Medical Centre, Leiden, Netherlands., Lehr T; Clinical Pharmacy, Saarland University, Saarbrücken, Germany., Mitropoulou C; The Golden Helix Foundation, London, UK; Department of Genetics and Genomics, College of Medicine and Health Sciences, United Arab Emirates University, Al-Ain, Abu Dhabi, United Arab Emirates., Rial-Sebbag E; Universite de Toulouse III Paul Sabatier, Toulouse, France., Rollinson V; Department of Pharmacology and Therapeutics, Wolfson Centre for Personalised Medicine, The University of Liverpool, Liverpool, UK., Roncato R; Experimental and Clinical Pharmacology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy., Samwald M; Centre for Medical Statistics, Informatics and Intelligent Systems, Institute of Artificial Intelligence, Medical University of Vienna, Vienna, Austria., Schaeffeler E; Dr Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany; iFIT Cluster of Excellence (EXC2180)-Image Guided and Functionally Instructed Tumour Therapies, University of Tuebingen, Tuebingen, Germany., Skokou M; University of Patras School of Health Sciences, Department of Pharmacy, Division of Pharmacology and Biosciences, Laboratory of Pharmacogenomics and Individualised Therapy, Patras, Greece., Schwab M; Dr Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany; iFIT Cluster of Excellence (EXC2180)-Image Guided and Functionally Instructed Tumour Therapies, University of Tuebingen, Tuebingen, Germany; Department of Clinical Pharmacology, University of Tuebingen, Tuebingen, Germany; Department of Pharmacy and Biochemistry, University of Tuebingen, Tuebingen, Germany., Steinberger D; Bio.logis Digital Health, Frankfurt am Main, Germany; Diagnosticum Centre for Humangenetics, Frankfurt am Main, Germany., Stingl JC; Institute of Clinical Pharmacology, University Hospital RWTH Aachen, Aachen, Germany., Tremmel R; Dr Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany., Turner RM; Department of Pharmacology and Therapeutics, Wolfson Centre for Personalised Medicine, The University of Liverpool, Liverpool, UK., van Rhenen MH; Medicines Information Centre, Royal Dutch Pharmacists Association (KNMP), The Hague, Netherlands., Dávila Fajardo CL; Clinical Pharmacy Department, Hospital Universitario Virgen de las Nieves, Instituto de Investigación Biosanitaria Granada, Granada, Spain., Dolžan V; Pharmacogenetics Laboratory, Institute of Biochemistry and Molecular Genetics, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia., Patrinos GP; Department of Genetics and Genomics, College of Medicine and Health Sciences, United Arab Emirates University, Al-Ain, Abu Dhabi, United Arab Emirates; Zayed Centre for Health Sciences, College of Medicine and Health Sciences, United Arab Emirates University, Al-Ain, Abu Dhabi, United Arab Emirates; University of Patras School of Health Sciences, Department of Pharmacy, Division of Pharmacology and Biosciences, Laboratory of Pharmacogenomics and Individualised Therapy, Patras, Greece; Erasmus University Medical Centre, Faculty of Medicine and Health Sciences, Department of Pathology-Clinical Bioinformatics Unit, Rotterdam, Netherlands., Pirmohamed M; Department of Pharmacology and Therapeutics, Wolfson Centre for Personalised Medicine, The University of Liverpool, Liverpool, UK., Sunder-Plassmann G; Department of Medicine III, Division of Nephrology and Dialysis, Medical University of Vienna, Vienna, Austria., Toffoli G; Experimental and Clinical Pharmacology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy., Guchelaar HJ; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Centre, Leiden, Netherlands. Electronic address: h.j.guchelaar@lumc.nl.

Publikováno v: Lancet (London, England) [Lancet] 2023 Feb 04; Vol. 401 (10374), pp. 347-356.

Pharmacogenomics decision support in the U-PGx project: Results and advice from clinical implementation across seven European countries.

Autor: Blagec K; Institute of Artificial Intelligence, Center for Medical Statistics, Informatics, and Intelligent Systems, Medical University of Vienna, Vienna, Austria., Swen JJ; Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, Leiden, The Netherlands., Koopmann R; Diagnosticum Center for Human Genetics, Frankfurt am Main, Germany.; Institute for Human Genetics, Justus Liebig University, Giessen, Germany., Cheung KC; Medicines Information Centre, Royal Dutch Pharmacists Association (KNMP), The Hague, The Netherlands., Crommentuijn-van Rhenen M; Medicines Information Centre, Royal Dutch Pharmacists Association (KNMP), The Hague, The Netherlands., Holsappel I; Medicines Information Centre, Royal Dutch Pharmacists Association (KNMP), The Hague, The Netherlands., Konta L; Diagnosticum Center for Human Genetics, Frankfurt am Main, Germany., Ott S; Institute of Artificial Intelligence, Center for Medical Statistics, Informatics, and Intelligent Systems, Medical University of Vienna, Vienna, Austria., Steinberger D; Diagnosticum Center for Human Genetics, Frankfurt am Main, Germany.; Institute for Human Genetics, Justus Liebig University, Giessen, Germany., Xu H; Institute of Artificial Intelligence, Center for Medical Statistics, Informatics, and Intelligent Systems, Medical University of Vienna, Vienna, Austria., Cecchin E; Experimental and Clinical Pharmacology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy., Dolžan V; Faculty of Medicine, Institute of Biochemistry and Molecular Genetics, Pharmacogenetics Laboratory, University of Ljubljana, Ljubljana, Slovenia., Dávila-Fajardo CL; Clinical Pharmacy Department, Hospital Universitario Virgen de las Nieves, Instituto de Investigación Biosanitaria Granada (Ibs.Granada), Granada, Spain., Patrinos GP; Department of Pharmacy, Laboratory of Pharmacogenomics and Individualized Therapy, University of Patras School of Health Sciences, Patras, Greece., Sunder-Plassmann G; Division of Nephrology and Dialysis, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria., Turner RM; The Wolfson Centre for Personalised Medicine, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, United Kingdom., Pirmohamed M; Department of Molecular and Clinical Pharmacology, Royal Liverpool University Hospital and University of Liverpool, Liverpool, United Kingdom., Guchelaar HJ; Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, Leiden, The Netherlands., Samwald M; Institute of Artificial Intelligence, Center for Medical Statistics, Informatics, and Intelligent Systems, Medical University of Vienna, Vienna, Austria.

Publikováno v: PloS one [PLoS One] 2022 Jun 08; Vol. 17 (6), pp. e0268534. Date of Electronic Publication: 2022 Jun 08 (Print Publication: 2022).

Pharmacogenetic polymorphisms affecting bisoprolol response.

Autor: Castaño-Amores C; Pharmacy Unit; Hospital Universitario clínico San Cecilio - Instituto de investigación biosanitaria (ibs.Granada), Granada, Spain., Díaz-Villamarín X; Pharmacy Unit; Hospital Universitario clínico San Cecilio - Instituto de investigación biosanitaria (ibs.Granada), Granada, Spain; Genomics Unit; Pfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research (GENyO), Granada, Spain. Electronic address: xdiaz@ibsgranada.es., Pérez-Gutiérrez AM; Department of Biochemistry and Molecular Biology II; School of Pharmacy, University of Granada, Granada, Spain., Antúnez-Rodríguez A; Genomics Unit; Pfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research (GENyO), Granada, Spain., Pozo-Agundo A; Genomics Unit; Pfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research (GENyO), Granada, Spain., Moreno-Escobar E; Cardiology Unit; Hospital Universitario clínico San Cecilio - Instituto de investigación biosanitaria (ibs.Granada), Granada, Spain., Sánchez-Ramos JG; Cardiology Unit; Hospital Universitario clínico San Cecilio - Instituto de investigación biosanitaria (ibs.Granada), Granada, Spain., Martínez-González LJ; Genomics Unit; Pfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research (GENyO), Granada, Spain., Dávila-Fajardo CL; Pharmacy Unit; Hospital Universitario Virgen de las Nieves - Instituto de investigación biosanitaria (ibs.Granada), Granada, Spain.

Publikováno v: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2021 Oct; Vol. 142, pp. 112069. Date of Electronic Publication: 2021 Aug 27.